Our finding is consistent with higher NPM1 expression observed in various cancer types, including prostate adenocarcinoma, lung adenocarcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, breast cancer, and bladder cancer. Here, NPM1 is linked to urinary bladder carcinoma.